|
|
||||||||
J. Biol. Chem., Vol. 267, Issue 20, 13803-13806, 07, 1992
PA Marcotte, IM Kozan, SA Dorwin and JM Ryan
The enzyme responsible for the metalloproteinase activity which cleaves the
Glu143-Leu144 bond of (pro)urokinase has been isolated from the conditioned
medium of cultured normal human kidney cells. Using S- Sepharose and
Cibacron Blue-agarose chromatography, then C-4 reversed phase high pressure
liquid chromatography, a protein of about 20,000 Da was isolated. Through
an identical amino-terminal sequence, the protein was shown to be the
matrix metalloproteinase previously referred to in the literature as
"pump-1" (putative metalloproteinase). When aprotinin was added during the
course of the purification, the major species isolated was the zymogen form
(28,000 Da) of pump-1. Pump-1 has been shown to efficiently cleave the
susceptible bond of both pro-urokinase (single-chain) and active
(two-chain) urokinase and thereby produce the corresponding low molecular
weight forms. The amino-terminal sequences of the A and B chains of low
molecular weight urokinase prepared by action of pump-1 on recombinant high
molecular weight urokinase are identical to those of the low molecular
weight urokinase isolated from human kidney cell culture. Since the
reaction of urokinase with this metalloproteinase results in separation of
its serine proteinase region from the domain which mediates binding to the
urokinase receptor, it may be of importance in the regulation of the
functional activity of the plasminogen activator in cellular processes.
The matrix metalloproteinase pump-1 catalyzes formation of low molecular weight (pro)urokinase in cultures of normal human kidney cells
Thrombolytics Venture, Pharmaceutical Products Division, Abbott Laboratories, Abbott Park, Illinois 60064.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
S.'i. Miyamoto, K. Yano, S. Sugimoto, G. Ishii, T. Hasebe, Y. Endoh, K. Kodama, M. Goya, T. Chiba, and A. Ochiai Matrix Metalloproteinase-7 Facilitates Insulin-Like Growth Factor Bioavailability through Its Proteinase Activity on Insulin-Like Growth Factor Binding Protein 3 Cancer Res., January 15, 2004; 64(2): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. HAJ-YEHIA, T. NASSAR, B. S. SACHAIS, A. KUO, K. BDEIR, A. B. AL-MEHDI, A. MAZAR, D. B. CINES, and A. A.-R. HIGAZI Urokinase-derived peptides regulate vascular smooth muscle contraction in vitro and in vivo FASEB J, July 1, 2000; 14(10): 1411 - 1422. [Abstract] [Full Text] |
||||
![]() |
C. L. Wilson, A. J. Ouellette, D. P. Satchell, T. Ayabe, Y. S. López-Boado, J. L. Stratman, S. J. Hultgren, L. M. Matrisian, and W. C. Parks Regulation of Intestinal -Defensin Activation by the Metalloproteinase Matrilysin in Innate Host Defense Science, October 1, 1999; 286(5437): 113 - 117. [Abstract] [Full Text] |
||||
![]() |
L. Lund, J Romer, N Thomasset, H Solberg, C Pyke, M. Bissell, K Dano, and Z Werb Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways Development, January 1, 1996; 122(1): 181 - 193. [Abstract] [PDF] |
||||
![]() |
S. R. Abramson, G. E. Conner, H. Nagase, I. Neuhaus, and J. F. Woessner Jr. Characterization of Rat Uterine Matrilysin and Its cDNA J. Biol. Chem., July 7, 1995; 270(27): 16016 - 16022. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |